G antigen 1 (9-16)

G antigen 1 (9-16) is a synthetic peptide fragment corresponding to amino acid residues 9 through 16 of the G antigen 1 protein sequence. As a defined peptide, it serves as a valuable tool in biochemical and immunological research, enabling precise interrogation of protein structure-function relationships and epitope mapping. Its sequence specificity and compatibility with standard peptide-handling protocols make it highly relevant for studies focused on antigenic determinants, molecular recognition, and protein-peptide interactions in both basic and applied research contexts.

Epitope Mapping: Researchers frequently utilize this peptide fragment to delineate the specific regions of G antigen 1 that are recognized by antibodies or T-cell receptors. By incorporating the 9-16 sequence into immunoassays or binding studies, investigators can systematically assess immune reactivity, facilitating the identification of minimal epitope regions. This approach supports the development of diagnostic reagents and enhances understanding of antigen-antibody specificity, which is critical for advancing immunological research and assay development.

Antibody Specificity Assessment: The defined sequence of G antigen 1 (9-16) is instrumental in evaluating the specificity and cross-reactivity of monoclonal and polyclonal antibodies raised against G antigen 1 or related proteins. By employing this peptide in enzyme-linked immunosorbent assays (ELISA), Western blotting, or surface plasmon resonance studies, scientists can confirm antibody binding to the intended epitope, optimize antibody selection, and reduce off-target effects in downstream applications.

Peptide-Protein Interaction Studies: The 9-16 peptide fragment enables detailed investigations into the molecular interactions between G antigen 1 and its potential binding partners. By using the peptide as a probe in pull-down assays, affinity chromatography, or biophysical binding experiments, researchers can elucidate the role of this specific sequence in mediating protein-protein or protein-ligand interactions. Such insights are fundamental for understanding signaling pathways, structural biology, and the functional consequences of sequence variation.

Synthetic Peptide Control: In experimental workflows requiring rigorous controls, this peptide serves as a reliable standard for validating assay performance, calibrating detection systems, or benchmarking experimental conditions. Its well-characterized sequence and reproducible synthesis support its use as a positive or negative control in immunoassays, mass spectrometry, and peptide quantification protocols, thereby enhancing the reliability and interpretability of experimental results.

Peptide-Based Assay Development: The availability of the G antigen 1 (9-16) fragment supports the design and optimization of peptide-based assays for research and screening purposes. By incorporating this sequence into assay platforms, scientists can develop sensitive detection systems for studying immune recognition, enzyme-substrate specificity, or molecular screening. Its defined length and sequence facilitate integration into multiplexed platforms and high-throughput screening, broadening its utility in both academic and industrial research settings.

1. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

3. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

4. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

5. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis